He felt healthy but routine blood tests revealed declining kidney function. His case highlights the silent progression of ...
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research ...
In the large, pivotal Phase 3 Launch-HTN trial, lorundrostat achieved similar significant blood pressure reductions in participants with and without CKD, with consistent reductions across Stages 1-3 C ...
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his ...
Octavia Spencer went in for a physical for an acting job and left with a type 2 diabetes diagnosis. The Oscar winner was in ...
CEB353Ge kit delivers critical molecular evidence for phase 3 clinical trial evaluating recombinant human serum albumin ...
The National Kidney Foundation (NKF) is highlighting a new Kidney Disease Outcomes Quality Initiative (KDOQI) commentary on the 2025 American Heart Association/American College of Cardiology guideline ...
A two-stage culture system expanded mouse hepatocytes and produced organoids with partial recovery of hepatic metabolism, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results